THC Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is August - July.

Millions USD. Fiscal year is Aug - Jul.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2016
Period Ending	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021	Jul '20 Jul 31, 2020	2019 - 2016
Net Income	-0.81	-0.39	-1.52	-1.89	-1.93	Upgrade
Depreciation & Amortization	0	0	0.01	0.02	0.02	Upgrade
Other Amortization	-	-	0.01	0.28	0.43	Upgrade
Stock-Based Compensation	0.22	0.09	0.84	0.12	0.44	Upgrade
Other Operating Activities	0.13	-0.19	-0.33	0.57	0.03	Upgrade
Change in Inventory	-	0	0	-0	-	Upgrade
Change in Accounts Payable	0.28	0.36	0.6	0.42	0.29	Upgrade
Change in Other Net Operating Assets	0	0.04	-0.04	0.1	0.14	Upgrade
Operating Cash Flow	-0.18	-0.09	-0.42	-0.39	-0.59	Upgrade
Other Investing Activities	-	-	-	-0.15	-	Upgrade
Investing Cash Flow	-	-	-	-0.15	-	Upgrade
Short-Term Debt Issued	0.09	0.04	0.13	0.09	0.58	Upgrade
Total Debt Issued	0.09	0.04	0.13	0.09	0.58	Upgrade
Short-Term Debt Repaid	-0	-0.05	-0.05	-0.1	-0.27	Upgrade
Total Debt Repaid	-0	-0.05	-0.05	-0.1	-0.27	Upgrade
Net Debt Issued (Repaid)	0.09	-0.01	0.07	-0.01	0.31	Upgrade
Issuance of Common Stock	-	0.1	0.15	0.51	-	Upgrade
Repurchase of Common Stock	-	-	-0.1	-	-	Upgrade
Financing Cash Flow	0.18	0.09	0.12	0.79	0.31	Upgrade
Net Cash Flow	0	-0	-0.3	0.25	-0.27	Upgrade
Free Cash Flow	-0.18	-0.09	-0.42	-0.39	-0.59	Upgrade
Free Cash Flow Per Share	-0.01	-0.00	-0.01	-0.02	-0.04	Upgrade
Levered Free Cash Flow	0.2	0.03	-0.05	0.16	0.18	Upgrade
Unlevered Free Cash Flow	0.29	0.08	-0.01	0.22	0.06	Upgrade
Change in Working Capital	0.28	0.4	0.56	0.51	0.43	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.